URBN
42
4
BA
49
-3
WM
76
3
GWW
71
4
BK
72
4
XYL
45
8
WU
30
6
MOS
46
4
THC
55
-4
HP
45
4
FDX
40
4
GS
73
7
WAT
53
6
HPE
61
6
NTAP
66
2
GILD
49
2
GRMN
64
2
AVGO
22
2
SYK
68
4
CMI
64
5
URBN
42
4
BA
49
-3
WM
76
3
GWW
71
4
BK
72
4
XYL
45
8
WU
30
6
MOS
46
4
THC
55
-4
HP
45
4
FDX
40
4
GS
73
7
WAT
53
6
HPE
61
6
NTAP
66
2
GILD
49
2
GRMN
64
2
AVGO
22
2
SYK
68
4
CMI
64
5
Financhill
Back

Adverum Biotechnologies Vs. EyePoint Pharmaceuticals Industry Stock Comparison

Sell
29

ADVM
Adverum Biotechnologies

Last Price:
6.05
Seasonality Move:
22.26%
Buy
55

EYPT
EyePoint Pharmaceuticals

Last Price:
8.94
Seasonality Move:
28.93%
Sell
29
Adverum Biotechnologies (ADVM) is a Sell

Is Adverum Biotechnologies a Buy, Sell or Hold?

  • The current Adverum Biotechnologies [ADVM] share price is $5.75. The Score for ADVM is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • ADVM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
EyePoint Pharmaceuticals (EYPT) is a Buy

Is EyePoint Pharmaceuticals a Buy, Sell or Hold?

  • The current EyePoint Pharmaceuticals [EYPT] share price is $8.35. The Score for EYPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • EYPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ADVM Stock Price Chart

What is Adverum Biotechnologies's stock price today?

  • The Adverum Biotechnologies share price today is $5.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADVM is experiencing selling pressure, which indicates risk of future bearish movement.

EYPT Stock Price Chart

What is EyePoint Pharmaceuticals's stock price today?

  • The EyePoint Pharmaceuticals share price today is $8.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing selling pressure, which indicates risk of future bearish movement.

ADVM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.36 Sell
Relative Strength Index (14 RSI): 24.35 Sell
Chaikin Money Flow: -683714 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.87 - 8.23) Sell
Bollinger Bands (100): (6.75 - 7.99) Sell

EYPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.32 Sell
Relative Strength Index (14 RSI): 35.82 Sell
Chaikin Money Flow: -1872551 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.53 - 11.89) Sell
Bollinger Bands (100): (8.13 - 10.51) Sell

ADVM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.82 Sell
20-day SMA: 7.38 Sell
50-day SMA: 7.42 Sell
200-day SMA: 9.89 Sell
8-day EMA: 6.64 Sell
20-day EMA: 7.16 Sell
50-day EMA: 7.38 Sell
200-day EMA: 8.8 Sell

EYPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.58 Sell
20-day SMA: 10.78 Sell
50-day SMA: 9.77 Sell
200-day SMA: 13.55 Sell
8-day EMA: 9.47 Sell
20-day EMA: 10.14 Sell
50-day EMA: 9.98 Sell
200-day EMA: 11.48 Sell

Adverum Biotechnologies Earnings Growth & ADVM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.56 per share, and an increase next year of $0.34 per share.

EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.31 per share.

Adverum Biotechnologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

EyePoint Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):